CME Group Inc. $CME Position Increased by Raiffeisen Bank International AG

Raiffeisen Bank International AG lifted its position in CME Group Inc. (NASDAQ:CME) by 69.5% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 8,128 shares of the financial services provider’s stock after buying an additional 3,333 shares during the quarter. Raiffeisen Bank International AG’s holdings in CME Group were worth $2,213,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Vanguard Group Inc. grew its position in CME Group by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 35,307,074 shares of the financial services provider’s stock worth $9,539,618,000 after purchasing an additional 130,698 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of CME Group by 3.6% in the second quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock worth $2,524,271,000 after buying an additional 319,899 shares during the period. Norges Bank purchased a new position in shares of CME Group during the second quarter valued at $1,571,447,000. Ameriprise Financial Inc. raised its position in CME Group by 2.0% during the second quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider’s stock valued at $1,289,910,000 after buying an additional 92,925 shares during the period. Finally, Arrowstreet Capital Limited Partnership lifted its stake in CME Group by 6.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,833,090 shares of the financial services provider’s stock worth $1,056,476,000 after acquiring an additional 238,522 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME’s formal announcement to offer 24/7 trading for crypto futures and options — a move that addresses the timing gap with always‑on spot crypto markets and could lift ADV and fee revenue; the company cited record crypto notional volume in 2025. CME Group to Launch 24/7 Cryptocurrency Futures and Options Trading on May 29
• Positive Sentiment: Widespread coverage emphasizes the practical impacts — continuous trading can reduce “CME gaps,” boost institutional flow and expand crypto derivatives ADV, supporting the bullish thesis for trading‑fee growth. CME targets May launch for 24/7 crypto derivatives trading
• Positive Sentiment: Analyst/fin‑media bullishness — some outlets include CME among top picks, arguing the firm converts market volatility into trading revenue, which supports the stock’s rally. 2 Best Stocks to Buy Right Now for February
• Neutral Sentiment: Macro/market context — broader market moves (small‑cap rotation and sector flows) could be influencing intraday moves in financials/exchanges but are not specific to CME’s fundamentals. Small Caps Stage Quiet Comeback As AI Trade Shows Cracks
• Neutral Sentiment: Reported short‑interest data appears immaterial or inconsistent (no meaningful change reported); it isn’t currently signaling a large positioning risk.
• Negative Sentiment: Insider selling — director Martin J. Gepsman sold 300 shares; small in size but noteworthy as a disclosed insider sale. Insider Sale: Martin J. Gepsman
• Negative Sentiment: Critical takeaways — at least one outlet warns of risks to the CME thesis (valuation and competitive/operational risks), which could temper enthusiasm if amplified by further negative coverage. 2 Reasons CME is Risky and 1 Stock to Buy Instead

CME Group Price Performance

NASDAQ CME opened at $308.09 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $111.10 billion, a PE ratio of 27.61, a price-to-earnings-growth ratio of 3.60 and a beta of 0.27. CME Group Inc. has a 12-month low of $246.91 and a 12-month high of $309.35. The company has a 50 day moving average price of $283.19 and a two-hundred day moving average price of $274.78.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the business posted $2.52 EPS. CME Group’s quarterly revenue was up 8.1% on a year-over-year basis. As a group, equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.7%. This is an increase from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date is Tuesday, March 10th. CME Group’s dividend payout ratio is 44.80%.

Insider Buying and Selling

In other news, Director Martin J. Gepsman sold 300 shares of the company’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $305.90, for a total transaction of $91,770.00. Following the completion of the sale, the director owned 24,999 shares in the company, valued at approximately $7,647,194.10. This represents a 1.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director William R. Shepard acquired 251 shares of the stock in a transaction dated Tuesday, December 30th. The shares were bought at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the acquisition, the director owned 258,710 shares in the company, valued at $72,017,102.70. The trade was a 0.10% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders sold 26,048 shares of company stock worth $7,054,920 over the last ninety days. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

CME has been the subject of a number of research reports. The Goldman Sachs Group raised their price objective on CME Group from $264.00 to $266.00 and gave the stock a “sell” rating in a research report on Monday, February 9th. Royal Bank Of Canada raised their price target on shares of CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a report on Thursday, February 5th. Jefferies Financial Group lowered their price objective on shares of CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a research report on Monday, January 12th. Bank of America increased their target price on shares of CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Finally, UBS Group reissued a “neutral” rating and set a $310.00 target price on shares of CME Group in a research note on Friday, February 6th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $299.53.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.